Literature DB >> 1285368

The effect of somatostatin, gabexate mesilate and dextran 40 on the microcirculation in sodium taurocholate-induced pancreatitis.

K Kusterer1, M Enghofer, T Poschmann, K H Usadel.   

Abstract

In vivo microscopy was performed to assess the effect of dextran 40, gabexate mesilate and somatostatin on the microcirculation in sodium taurocholate-induced pancreatitis in rats. Intraductal infusion of 0.4 ml of a 4% solution of sodium taurocholate decreased capillary blood flow, induced capillary stasis and increased vascular permeability in the head of the pancreas. Dextran 40, gabexate mesilate and somatostatin improved capillary blood flow in the initial phase of acute pancreatitis significantly and prevented stasis in 5 of 9, 3 of 8 and 7 of 10 (p < 0.05) cases. Only dextran 40 reduced the increase of vascular permeability. Decrease of capillary blood flow, capillary stasis and vascular permeability changes are important factors contributing to the pathogenesis of sodium taurocholate-induced pancreatitis. Dextran 40, gabexate mesilate and somatostatin exert a beneficial effect on the microcirculatory changes in this model of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285368

Source DB:  PubMed          Journal:  Acta Physiol Hung        ISSN: 0231-424X


  3 in total

Review 1.  Influencing factors of pancreatic microcirculatory impairment in acute panceatitis.

Authors:  Zong-Guang Zhou; You-Dai Chen
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  Dexamethasone and dextran 40 treatment of 32 patients with severe acute pancreatitis.

Authors:  Zi-Fa Wang; Chang Liu; Yi Lu; Rui Dong; Jun Xu; Liang Yu; Ying-Min Yao; Qing-Guang Liu; Cheng-En Pan
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

3.  Beneficial effect of octreotide treatment in acute pancreatitis in rats.

Authors:  J Marton; Z Szasz; Z Nagy; K Jarmay; T Takacs; J Lonovics; A Balogh; G Farkas
Journal:  Int J Pancreatol       Date:  1998-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.